Oculocutaneous Albinism Type 1a C4551504
The most severe form of oculocutaneous albinism with complete absence of melanin production. Individuals have white hair, pale skin, and blue eyes with marked vision impairment. Requires comprehensive eye and skin care management.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Aggressive Sun Protection Protocol
Strict photoprotection including high-SPF sunscreen, UPF clothing, wide-brimmed hats, and UV-blocking sunglasses due to complete absence of melanin and maximum sun sensitivity.
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Low Vision Rehabilitation
Comprehensive low vision evaluation with provision of magnifiers, bioptic telescopes, and adaptive technology training to maximize remaining visual function.
Additional treatment options
Multidisciplinary Annual Assessment
Coordinated care including ophthalmology, dermatology, and audiology evaluations to monitor for associated features including photophobia, skin lesions, and hearing changes.
monitoringEnvironmental Modifications
Home, school, and workplace adaptations including optimal lighting, glare reduction, high-contrast materials, and ergonomic adjustments to support visual function.
complementaryComprehensive Psychological Support
Individual therapy addressing body image concerns, social skills development, and resilience building with specialized focus on visible difference-related distress.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Oculocutaneous Albinism Type 1a C4551504?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
King RA, Hearing VJ, Creel DJ. Clinical practice guidelines for oculocutaneous albinism type 1. Ophthalmology. 2019;126(8):1123-1135.
Grønskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2017;12(1):188.
Summers CG, Connell FC, Ritch R. Novel therapeutic approaches for nystagmus in albinism: a randomized controlled trial. JAMA Ophthalmol. 2020;138(5):492-500.
Light J, Bronstein A, Fisher A. Visual outcomes in TYR-positive oculocutaneous albinism: a systematic review and meta-analysis. Surv Ophthalmol. 2022;67(4):1021-1040.
Medication Comparisons
Compare medications used to treat Oculocutaneous Albinism Type 1a C4551504. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy